Manage Your Liver
Q:

Cancer death rate has dropped, but liver cancer incidence continues to increase rapidly in women and stabilizing in men

Cancer death rate has dropped, but liver cancer incidence continues to increase rapidly in women and stabilizing in men
A:

The overall cancer death rate in the USA declined by 1.7 percent in 2015, this is the latest indication of steady, long-term progress against the disease, according to a new report by the American Cancer Society. However, look into the report in more detail we can see a continued increase of liver cancer cases, especially in women.

 

Over nearly a quarter-century, the mortality rate has fallen 26 percent, resulting in almost 2.4 million fewer deaths than if peak rates had continued. But not for liver cancer, the number of liver cancer death has increased with the latest estimated deaths of liver cancer is 30,200 in 2018.

 

“Liver cancer incidence continues to increase rapidly in women, but appears to be plateauing in men since 2010. However, trends vary by age; from 2010 to 2014, rates increased annually by 1% to 2% in men and women aged younger than 40 years, decreased or were stable in men and women aged 40 to 59 years, and increased annually by 8% in individuals aged 60 to 69 years and by 3% in those aged 70 years and older.”

 

Difficulties in liver cancer treatment

 

When treating liver cancer it is often difficult as there are little symptoms in the early stages of the disease, and the tumor is often developed into a more advanced stages leading to difficulties in treatment, leading to a high percentage of death cases, also because our liver is used to process toxins and made new blood, it can quickly spread it to other parts of our body.

 

From the latest report’s there is a prediction of more than 67% death rates for men, and even higher for women.

Prevention and minimise risks

 

As liver cancer is hard to spot without testings and scans, people who are at high risks of liver cancer are recommended to have regular liver check-ups, these include people with High ALT level, chronic liver disease, people with liver fibrosis, cirrhosis, or other viral hepatitis, people who are cured of hepatitis C are also still in risks of liver as research shows that people can develop liver cancer after successful DAAs treatments. According to the liver foundations, high risks patients should monitor their liver health every 6 to 12 months.

 

Protective therapy against abnormal liver cells growth

 

YHK therapy is a scientifically based natural liver support; research shows that YHK can efficiently help to prevent the growth of abnormal liver cells and to maintain healthy, normal liver function. This effect is especially useful for people who are at high risks to use as a preventive measure.

Research of YHK on the subject (published by Annals of Hepatology), wrote:

“These data suggest that YHK seem to modulate the extrinsic and intrinsic regulators of apoptosis and sensitize tumour cells to apoptosis. These preliminary data are worth interest when considering that this nutraceutical has been shown in vitro and in vivo to exert protective anti-tumour effect by redox status- modulating and immunoregulatory actions. 

 

Given its lack of toxicity so far reported, such natural product might represent an effective nutritional supplement in some pathological conditions where a chemopreventive strategy is planned.”

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Since the introduction of direct-acting antiviral (DAA) therapy, treatment for hepatitis C (HCV) was revolutionized, as patient outcomes are improved with fewer side effects and high cure rate. However, there is significant debate in the society based on studies that suggest HCV cure does not eliminate risk for hepatocellular carcinoma (HCC) or liver cancer. Other research suggests the possibility of increased risk of developing liver cancer during and after DAA treatment in patients with hep
A:
Chronic hepatitis C is a slow and progressive disease that causes liver inflammation, fibrosis and cirrhosis. Over a long period of time, hepatitis virus can cause long term damage that is often thought to be irreversible. But recent research is suggesting otherwise, that fibrotic or cirrhotic liver is reversible, allowing patients to regain liver function and improve health. The danger of cirrhosis Cirrhosis is end stage liver fibrosis, it is a
Hit Questions
A:
The liver carries out essential functions, including detoxifying harmful substances in your body, cleaning your blood and making new blood and other vital nutrients. Cirrhosis is scarring of the liver caused by long-term liver damage. The loss of liver cells turns into scar tissue which prevents the liver working normally, reducing or in some cases, completely losing liver function. Cirrhosis is a long-term chronic liver damage; it is often caused by chronic live
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us
Subscribe To Our Mailing List And
Never Miss Another Great Promotion!
Join our mailing list to receive latest new about our company, plus health articles. You will also be able to receive early bird discount from us!
Maybe Later, Thank you.
Subscribe success! You will receive latest new soon.